Louisiana adopts 'Netflix' model to pay for hepatitis C drugs - (The Washington Post via NewsPoints Desk)

  • Louisiana is adopting a subscription-style model to cover expensive hepatitis C drugs, Washington Post reported.

  • Under the model, the state will pay a flat rate for unlimited access to drugs, opposed to paying for products individually.

  • "I've had conversations with a number of governors to make sure they're aware of what we’re doing — and if and when we're successful, we're going to have something worthy of emulation and replication around the country," remarked Louisiana Governor John Bel Edwards.

  • The state aims to treat 10 000 people with hepatitis C by 2020, compared to the 1000 people treated last year at a cost of $35 million.

  • Hepatitis C drug manufacturers AbbVie and Gilead Sciences have both expressed support for the model.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.